1. Home
  2. HOV vs EOLS Comparison

HOV vs EOLS Comparison

Compare HOV & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hovnanian Enterprises Inc.

HOV

Hovnanian Enterprises Inc.

N/A

Current Price

$104.65

Market Cap

592.5M

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$7.23

Market Cap

500.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOV
EOLS
Founded
1959
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
592.5M
500.0M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
HOV
EOLS
Price
$104.65
$7.23
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
106.9K
★ 669.7K
Earning Date
12-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.23
EPS
★ 1.55
N/A
Revenue
★ $2,978,581,000.00
$297,176,000.00
Revenue This Year
N/A
$12.44
Revenue Next Year
$4.52
$17.37
P/E Ratio
$64.32
★ N/A
Revenue Growth
N/A
★ 11.61
52 Week Low
$90.17
$3.86
52 Week High
$148.48
$9.31

Technical Indicators

Market Signals
Indicator
HOV
EOLS
Relative Strength Index (RSI) 49.94 44.48
Support Level $90.85 $6.99
Resistance Level $118.46 $7.28
Average True Range (ATR) 5.67 0.35
MACD 1.20 0.02
Stochastic Oscillator 91.47 38.71

Price Performance

Historical Comparison
HOV
EOLS

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: